...
首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Safety and Efficacy of Subcutaneous Parenteral Nutrition in Older Patients: A Prospective Randomized Multicenter Clinical Trial
【24h】

Safety and Efficacy of Subcutaneous Parenteral Nutrition in Older Patients: A Prospective Randomized Multicenter Clinical Trial

机译:患者皮下肠外营养的安全性和有效性:一项前瞻性随机化多中心临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Many patients who cannot tolerate adequate enteral nutrition could benefit from parenteral nutrition support but fail to receive it due to difficult intravenous (IV) access. The objective of this study was to compare the safety and efficacy of subcutaneous (SC) administration of parenteral nutrition with the peripheral IV route. Materials and Methods: This was a prospective randomized multicenter study of 121 older hospitalized patients. The primary outcome was the composite end point of major local side effects, defined as local edema, blistering, erythema, phlebitis, cellulitis, unbearable pain, or route failure requiring a switch in route. Secondary outcomes were nutrition parameters, biochemical parameters, clinical outcomes, and safety. Results: The SC route (n = 59) was noninferior to the IV route (n = 61) for major local side effects. Major local side effects trended higher in the IV group (P = .059). Local edema was more common in the SC group (P < .05), while route failure was more common in the IV group (P < .001). Nutrition and biochemical parameters, safety, and clinical outcomes were similar between groups. Conclusions: The SC route of nutrient administration was better tolerated than the peripheral IV route. SC administration of parenteral nutrition represents a safe alternative to IV nutrition.
机译:背景:许多不能容忍充足的肠内营养的患者可以从肠外营养支持中受益,但由于静脉内(IV)访问而未能接受它。本研究的目的是将皮下(SC)给予外周IV途径给予肠外营养的安全性和疗效。材料和方法:这是121名较旧住院患者的前瞻性随机多中心研究。主要结果是主要局部副作用的复合终点,定义为局部水肿,起泡,红斑,静脉炎,蜂窝织炎,难以忍受的疼痛,或者在路线中需要开关的路线故障。二次结果是营养参数,生物化学参数,临床结果和安全性。结果:SC路线(n = 59)不受IV路线(n = 61),用于主要局部副作用。 IV组的主要局部副作用趋势更高(P = .059)。局部水肿在SC组中更常见(P <.05),而IV组中的路线故障更常见(P <.001)。营养和生物化学参数,安全和临床结果之间是相似的。结论:营养施用的SC途径比外周IV途径更好。 SC授权肠外营养代表了IV营养的安全替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号